ReviewSurgery today2008
Intestinal tissue engineering: where do we stand?
Review in Surgery today, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement.Surgery today · 2013Review
- Regenerative surgery: tissue engineering in general surgical practice.World journal of surgery · 2012Review
- ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.Pediatric surgery international · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue engineering has revolutionized the medical field by giving us the hope of generating alternative human tissues that could replace diseased ones. On this front, the generation of tissue-engineered neo-intestine in animal models has been a great endeavor with the ultimate goal of replacing the diseased gut or to treat short gut syndrome. Although this field and the generated neo-intestine are still in their infancy, this idea is so attractive that it has fascinated all medical personnel including gastroenterologists and gastrointestinal surgeons. We herein introduce the salient features of a tissue-engineered intestine, the hopes associated with it, and the few practical constraints in developing a "mature" human tissue-engineered intestine, which would be sufficient to treat short gut syndrome.
Indexed as
Identifiers
18516525What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.